【无锡】近日，无锡途深智合人工智能科技有限公司及旗下上海途深生物科技有限责任公司（简称「途深智合」）成功获得诚美资本的数百万元天使轮融资。此轮融资将主要用于加强实验室设施建设和团队扩充，以推动公司在AI蛋白质设计与优化领域的前沿探索。
「途深智合」成立于2023年，是一家专注于人工智能技术在蛋白质设计和制造中的应用的生物科技新秀。公司致力于为合成生物学领域提供创新的解决方案和新产品，以满足行业对高效、精准的蛋白质设计日益增长的需求。通过将AI算法与生物科学相结合，「途深智合」有望打破传统蛋白质工程的瓶颈，加速新药研发和生物技术的进步。
诚美资本的投资彰显了市场对「途深智合」技术实力和未来发展前景的认可。随着生物科技与人工智能的深度融合，「途深智合」有望成为该领域的领军企业，推动中国乃至全球的生物科技产业创新与发展。此轮融资的成功，不仅为「途深智合」的科研创新注入了新的活力，也将助力公司在竞争激烈的生物科技市场中抢占先机。
英语如下：
News Title: “Tushen Zhihe Secures Angel Round Investment in Millions, Accelerating AI Protein Design Innovation”
Keywords: Tushen Zhihe, AI Proteins, Angel Financing
News Content: **Wuxi** – Recently, Wuxi Tushen Zhihe Artificial Intelligence Technology Co., Ltd. and its subsidiary, Shanghai Tushen Biological Technology Co., Ltd. (collectively known as “Tushen Zhihe”), successfully secured millions of yuan in angel financing from Chengmei Capital. This funding will mainly be used to enhance laboratory facilities and expand the team, driving the company’s cutting-edge exploration in AI protein design and optimization.
Founded in 2023, Tushen Zhihe is a biotech startup specializing in the application of artificial intelligence technology in protein design and manufacturing. The company aims to provide innovative solutions and new products to the synthetic biology sector, addressing the growing demand for efficient and precise protein design. By combining AI algorithms with bio-science, Tushen Zhihe is poised to break through the bottlenecks of traditional protein engineering, accelerating drug discovery and advancements in biotechnology.
Chengmei Capital’s investment demonstrates the market’s recognition of Tushen Zhihe’s technological prowess and future growth potential. With the deep integration of biotechnology and AI, Tushen Zhihe is poised to become a leading player in the field, driving innovation and development in the biotech industry both in China and globally. This successful financing round not only injects new vitality into Tushen Zhihe’s research and innovation but also positions the company to seize a competitive advantage in the fiercely contested biotech market.
【来源】https://36kr.com/p/2686282258132355
Views: 1